Case Study
AI will Functions not as a Diagnostic System or Alerting Overlay, but as a Utilization Management Enabler that Strengthens Existing Clinical and Regulatory Workflows
U.S. Pharma Consulting (USPC), in collaboration with Miracural AI (DeepDrug AI), has been operatingat the leading edge of the mission critical data ecosystem shift, with our EHR - compendia andmedication risk framework closely aligned to, and subsequently validated by - CMS’s Health TechEcosystem direction articulated by Dr. Mehmet Oz at JPM 2026 9, reinforcing the relevance of thisapproach across drug development, pharmacovigilance, and broader pharma revenue-stacking datagap opportunities.
Please fill out the form to download the Case Study or Slide Deck
Thank you. We'll be in touch shortly.
Oops! Something went wrong while submitting the form.